Immunotherapy Updates in Advanced Hepatocellular Carcinoma

Immunotherapy Updates in Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. HCC tumor development and treatment resistance are impacted by changes in the microenvironment of the hepatic immune system. Immunotherapy has the potential to improve response rates by overcoming immune tolera...

Full description

Bibliographic Details
Main Authors: Amisha Singh, Ryan J. Beechinor, Jasmine C. Huynh, Daneng Li, Farshid Dayyani, Jennifer B. Valerin, Andrew Hendifar, Jun Gong, May Cho
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
hepatocellular carcinoma
immunotherapy
immune checkpoint inhibitors
PD-1
PD-L1
CTLA-4
Online Access:https://www.mdpi.com/2072-6694/13/9/2164

Internet

https://www.mdpi.com/2072-6694/13/9/2164

Similar Items